BACKGROUND: Reducing circulating levels of fibroblast growth factor-23 (FGF-23) in patients on renal replacement therapy (RRT) could appear as an appealing approach for cardiovascular events prevention. The purpose of our study was to compare the clearance of FGF-23 between high flux hemodialysis (HD) and on-line hemodiafiltration (OL-HDF) procedures. METHODS: Fifty-three patients were included in the HD group while 32 patients were included in the OL-HDF group. Serum pre- and post-dialysis FGF-23 levels were measured using a 2nd generation Human FGF-23 (C-Term) ELISA kit. RESULTS: Mean FGF-23 reduction rates were significantly higher in OL-HDF (55.7 ± 25.2%) versus HD (36.2 ± 28.6%) groups (P=.0001), as were calculated FGF-23 clearances (P=.015) and Kt/V-FGF-23 (P=.001). Overall, post-treatment FGF-23 levels were significantly lower than pre-treatment values in both groups (P<.01). CONCLUSIONS: OL-HDF achieves higher FGF-23 removal over high flux HD.
BACKGROUND: Reducing circulating levels of fibroblast growth factor-23 (FGF-23) in patients on renal replacement therapy (RRT) could appear as an appealing approach for cardiovascular events prevention. The purpose of our study was to compare the clearance of FGF-23 between high flux hemodialysis (HD) and on-line hemodiafiltration (OL-HDF) procedures. METHODS: Fifty-three patients were included in the HD group while 32 patients were included in the OL-HDF group. Serum pre- and post-dialysis FGF-23 levels were measured using a 2nd generation HumanFGF-23 (C-Term) ELISA kit. RESULTS: Mean FGF-23 reduction rates were significantly higher in OL-HDF (55.7 ± 25.2%) versus HD (36.2 ± 28.6%) groups (P=.0001), as were calculated FGF-23 clearances (P=.015) and Kt/V-FGF-23 (P=.001). Overall, post-treatment FGF-23 levels were significantly lower than pre-treatment values in both groups (P<.01). CONCLUSIONS: OL-HDF achieves higher FGF-23 removal over high flux HD.
Authors: Paulo Giovanni de Albuquerque Suassuna; Rogério Baumgratz de Paula; Hélady Sanders-Pinheiro; Orson W Moe; Ming-Chang Hu Journal: J Nephrol Date: 2018-11-14 Impact factor: 3.902
Authors: Jordana D Lima; Murilo Guedes; Roberto Pecoits-Filho; Lia S Nakao; Silvia D Rodrigues; Ana Clara S Flórido; Andrea N Moreno-Amaral; Ana Beatriz Barra; Maria Eugênia Canziani; Américo Cuvello-Neto; Carlos Eduardo Poli-de-Figueiredo Journal: J Nephrol Date: 2022-03-03 Impact factor: 4.393
Authors: Andreas Schneider; Markus P Schneider; Detlef H Krieter; Bernd Genser; Hubert Scharnagl; Tatjana Stojakovic; Christoph Wanner; Christiane Drechsler Journal: PLoS One Date: 2015-05-29 Impact factor: 3.240
Authors: Jochen G Raimann; Joseph Marfo Boaheng; Philipp Narh; Harrison Matti; Seth Johnson; Linda Donald; Hongbin Zhang; Friedrich Port; Nathan W Levin Journal: Sci Rep Date: 2020-07-06 Impact factor: 4.379
Authors: Marijke Dekker; Andreas Pasch; Frank van der Sande; Constantijn Konings; Matthias Bachtler; Mauro Dionisi; Matthias Meier; Jeroen Kooman; Bernard Canaud Journal: PLoS One Date: 2016-04-11 Impact factor: 3.240